[Federal Register Volume 69, Number 189 (Thursday, September 30, 2004)]
[Notices]
[Page 58539]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-21957]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated May 5, 2004, and published in the Federal Register 
on May 26, 2004, (69 FR 29979), Boehringer Ingelheim Chemicals Inc., 
2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the basic classes of controlled substances:

 
------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Methadone (9250)...........................  II
Methadone Intermediate (9254)..............  II
Dextropropoxyphene (9273)..................  II
Levo-alphacetylmethadol (9648).............  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
for formulation into finished pharmaceuticals.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Boehringer Ingelheim Chemicals Inc. to manufacture the basic classes of 
controlled substances listed is consistent with the public interest at 
this time. DEA has investigated Boehringer Ingelheim Chemicals Inc. to 
ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823, and in 
accordance with 21 CFR 1301.33, the above named company is granted 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed.

    Dated: September 16, 2004,
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-21957 Filed 9-29-04; 8:45 am]
BILLING CODE 4410-09-M